norvaline and Metabolic Syndrome

norvaline has been researched along with Metabolic Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
El-Bassossy, HM; El-Fawal, R; Fahmy, A; Watson, ML	1

Other Studies

1 other study(ies) available for norvaline and Metabolic Syndrome

Article	Year
Arginase inhibition alleviates hypertension in the metabolic syndrome. British journal of pharmacology, 2013, Volume: 169, Issue:3 Topics: Animals; Antihypertensive Agents; Aorta, Thoracic; Arginase; Blood Pressure; Citrulline; Endothelium, Vascular; Enzyme Inhibitors; Hyperinsulinism; Hypertension; Hypertriglyceridemia; Hypolipidemic Agents; Insulin Resistance; Male; Metabolic Syndrome; Nitric Oxide; Ornithine; Random Allocation; Rats; Rats, Wistar; Reactive Oxygen Species; Valine	2013

Article

Year

Arginase inhibition alleviates hypertension in the metabolic syndrome.

British journal of pharmacology, 2013, Volume: 169, Issue:3

Topics: Animals; Antihypertensive Agents; Aorta, Thoracic; Arginase; Blood Pressure; Citrulline; Endothelium, Vascular; Enzyme Inhibitors; Hyperinsulinism; Hypertension; Hypertriglyceridemia; Hypolipidemic Agents; Insulin Resistance; Male; Metabolic Syndrome; Nitric Oxide; Ornithine; Random Allocation; Rats; Rats, Wistar; Reactive Oxygen Species; Valine

2013